Monoclonal antibody(AD5-10) against tumor necrosis factor-related apoptosisinducing ligand receptor DR5, the producing method and uses thereof

Details for Australian Patent Application No. 2005274579 (hide)

Owner The Institute of Basic Medical Sciences of Chinese Academy of Medical Sciences

Inventors Liu, Yanxin; Zheng, Dexian; Guo, Yabin

Agent Fisher Adams Kelly

Pub. Number AU-B-2005274579

PCT Pub. Number WO2006/017961

Priority 200410070093.1 19.08.04 CN

Filing date 7 March 2005

Wipo publication date 23 February 2006

Acceptance publication date 14 October 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

A61P 39/00 (2006.01) General protective or antinoxious agents

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/18 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Murine cells, e.g. mouse cells

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

7 September 2006 PCT application entered the National Phase

  PCT publication WO2006/017961 Priority application(s): WO2006/017961

14 October 2010 Application Accepted

  Published as AU-B-2005274579

10 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005274614-Square MBR manifolding system

2005274578-A detoxifizyme having activity of transforming aflatoxin and the gene encodes thereof